(Reuters) – Shell said on Thursday it will build a 100-megawatt renewable hydrogen electrolyser in Germany, the company’s second unit in Europe, which will help it reduce carbon emissions at its refineries. The Refhyne II electrolyser at the Rheinland refinery is scheduled to begin operating in 2027 and produce up to 44,000 kilograms per day of …
Shell to build renewable hydrogen electrolyser in Germany Read More »
By Tim Hepher, Allison Lampert and David Shepardson FARNBOROUGH, England (Reuters) – The world’s largest air show fizzled out on Thursday with a solid new Saudi jetliner order unable to dispel the gloom over recent problems in producing planes fast enough to meet demand. Britain’s Farnborough Airshow opened earlier this week amid alarm signals from …
Jetmaking industrial problems overshadow orders at damp air show Read More »
By Christoph Steitz FRANKFURT (Reuters) -German conglomerate Thyssenkrupp on Thursday cut its full-year outlook, citing weak demand for its products that is not expected to stabilise in the short-term and sending its shares lower in late Frankfurt trade. The company, which makes steel, submarines and car parts, warned that measures of an efficiency programme launched …
Germany’s Thyssenkrupp cuts outlook as market environment remains weak Read More »
MILAN (Reuters) -The head of eyewear company EssilorLuxottica said Meta had informed him that it might take a stake in the company, adding on Thursday that he would welcome such a step. The comments from CEO Francesco Milleri follow media reports last week that Meta could invest in the Ray-Ban maker. The Wall Street Journal …
EssilorLuxottica says Meta told it about potential investment Read More »
LONDON (Reuters) -Tom Hayes, the first trader jailed worldwide for interest rate rigging, has been given permission to appeal against his conviction at Britain’s Supreme Court, his lawyers said on Thursday. Hayes, a former star Citigroup and UBS trader, was convicted in 2015 of conspiracy to defraud by manipulating Libor, a benchmark rate once used …
By Jonathan Stempel (Reuters) – Monsanto will pay $160 million to settle a lawsuit by the city of Seattle that accused the unit of Germany’s Bayer of polluting the city’s drainage system and the local Lower Duwamish River with toxic chemicals known as PCBs. City Attorney Ann Davison announced the settlement on Thursday, calling it …
Bayer’s Monsanto to pay $160 million to resolve Seattle’s PCB contamination lawsuit Read More »
By Jan Strupczewski and Marcela Ayres RIO DE JANEIRO (Reuters) – Brazil’s idea to tax the world’s super-rich to reduce inequality was well received at a meeting of G20 finance ministers this week, but will be very challenging to implement, top European and U.S. officials said on Thursday. With its presidency of the Group of …
Brazil’s “billionaire tax” idea well received at G20, but seen as difficult to implement Read More »
By Francesca Landini MILAN (Reuters) -Italian utility Enel said on Thursday it would pay a dividend on its 2024 results above the group’s planned floor, after reporting a 9% rise in its first-half core profit. “Results registered and the visibility on the second half of the year position us in the high end of the …
Enel pledges higher dividend after 9% rise in H1 core profit Read More »
By Paul Sandle LONDON (Reuters) -Vodafone reported a slow down in top-line growth on Thursday, ending four quarters of accelerating improvement, after law changes related to selling TV services in Germany caused its largest market to go into reverse. The European and African mobile operator said the decline in Germany was expected and it was …
Vodafone’s growth slows as Germany goes into reverse Read More »
By Ludwig Burger FRANKFURT (Reuters) -Roche on Thursday raised its full-year earnings forecast after exceeding expectations for the first half, driven by strong demand for newer drugs such as eye medicine Vabysmo. The Swiss drugmaker said it expects growth in adjusted earnings in the “high single-digit range”, excluding the effect of currency swings and resolution …
Roche lifts 2024 profit guidance on strong drug sales Read More »
